Evaluation of symptoms in Duchenne muscular dystrophy: a palliative care strategy

Authors

  • Josiane Rosires Pavão Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - FMRP-USP
  • Elisângela Aparecida da Silva Lizzi Universidade Tecnológica Federal do Paraná - UTFPR
  • Mariana Angélica de Souza Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - FMRP-USP
  • Cláudia Ferreira da Rosa Sobreira Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - FMRP-USP
  • Thais Cristina Chaves Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - FMRP-USP
  • Ana Claudia Mattiello-Sverzut Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - FMRP-USP

DOI:

https://doi.org/10.11606/issn.2317-0190.v27i2a171476

Keywords:

Muscular Dystrophy, Duchenne, Palliative Care, Symptom Assessment

Abstract

Symptom assessment, in Duchenne Muscular Dystrophy (DMD), allows an adequate treatment, and the Edmonton Symptom Assessment System (ESAS) assess it:  evaluating clinical problems of patients in palliative care (pain, tiredness, drowsiness, nausea, appetite, shortness of breath, depression, anxiety, and well-being). Objective: To verify if patients with DMD understand the terms of the ESAS and if their symptoms could be assessed using this instrument. Methods: Ten patients with DMD were cross-sectional  evaluated in relation to the understanding of the ESAS items, capacity to describe symptom (using the ESAS and the Faces Scale) and the Motor Function Measure. The patient’s symptom by ESAS was also classified by evaluator. A descriptive and correlation (Spearman's correlation coefficient) analysis of data was performed. Results: All patients understood the symptoms of pain, tiredness, drowsiness, depression (sadness), and well-being. However, some patients did not understand the symptoms of nausea, appetite, shortness of breath. The general mean of all symptoms assessed by the ESAS was below 5 points. For the symptom ‘depression’ and ‘anxiety’, a strong correlation was found between the results of the ESAS and the Face scale (r= 0.64, and r= 0.65, respectively). Additionally, a perfect and strong correlation, respectively, was found between the ESAS completed by the patient and the evaluator for the items '‘depression’," and ‘anxiety’ (r= 1.0)" and a ‘drowsiness’ (r= 0.82). Conclusion: DMD patients understood the ESAS terms and graded their symptoms using this instrument. Therefore, it is not necessary to change the ESAS terms to assess patients with DMD.

Downloads

Download data is not yet available.

References

Humbertclaude V, Hamroun D, Bezzou K, Bérard C, Boespflug-Tanguy O, Bommelaer C, et al. Motor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials. Eur J Paediatr Neurol. 2012;16(2):149–60. Doi: https://doi.org/10.1016/j.ejpn.2011.07.001

Silva TDD, Massetti T, Monteiro CBDM, Trevizan IL, Arab C, Caromano FA, et al. Pain characterization in Duchenne muscular dystrophy. Arquivos de neuro-psiquiatria. 2016;74(9),767-74. Doi: http://dx.doi.org/10.1590/0004-282X20160107

Pangalila RF, van den Bos GA, Bartels B, Bergen M, Stam HJ, Roebroeck ME. Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil. 2015;96(7):1242-7. Doi: https://doi.org/10.1016/j.apmr.2015.02.012

Carter GT, Joyce NC, Abresch AL, Smith AE, VandeKeift GK. Using palliative care in progressive neuromuscular disease to maximize quality of Life. Phys Med Rehabil Clin N Am. 2012;23(4):903–9. Doi: http://dx.doi.org/10.1016/j.pmr.2012.08.002

Carvalho RT, Parsons, HA. Manual de cuidados paliativos ANCP: ampliado e atualizado. São Paulo: Academia Nacional de Cuidados Paliativos (ANCP); 2012.

Organización Mundial de la Salud. Cuidados paliativos [texto na Internet]. Geneva: WHO; c2020 [citado 2020 Jun 21]. Disponível em: https://www.who.int/es/news-room/fact-sheets/detail/palliative-care

Rushton CH, Erby LH, Cohn RD, Geller G. Integrating palliative care in life-limiting pediatric neuromuscular conditions: the case of SMA-type 1 and Duchene muscular dystrophy. J Palliat Care Med. 2012; 2(1), 103. Doi: http://dx.doi.org/10.4172/2165-7386.1000103

Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6-9. Doi: https://doi.org/10.1177/082585979100700202

Paiva CE, Manfredini LL, Paiva BS, Hui D, Bruera E. The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients. PLoS One. 2015 8;10(7):e0132073. Doi: https://doi.org/10.1371/journal.pone.0132073

Davison SN, Jhangri GS, Johnson JA. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant. 2006;21(11):3189-95. Doi: https://doi.org/10.1093/ndt/gfl380

Shah AB, Udeoji DU, Baraghoush A, Bharadwaj P, Yennurajalingam S, Schwarz ER. An evaluation of the prevalence and severity of pain and other symptoms in acute decompensated heart failure. J Palliat Med. 2013;16(1):87-90. Doi: https://doi.org/10.1089/jpm.2012.0248

Walke LM, Gallo WT, Tinetti ME, Fried TR. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med. 2004; 164 (21): 2321-24. Doi: https://doi.org/10.1001/archinte.164.21.2321

Poonja Z, Brisebois A, van Zanten SV, Tandon P, Meeberg G, Karvellas CJ. Patients with cirrhosis and denied liver transplants rarely receive adequate palliative care or appropriate management. Clin Gastroenterol Hepatol. 2014;12(4):692-8. Doi: https://doi.org/10.1016/j.cgh.2013.08.027

Lopez G, Liles DK, Knupp CL. Edmonton Symptom Assessment System for outpatient symptom monitoring of sickle cell disease. South Med J. 2014;107(12):768-72. Doi: https://doi.org/10.14423/SMJ.0000000000000209

Hunt A, Carter B, Abbott J, Parker A, Spinty S, deGoede C. Pain experience, expression and coping in boys and young men with Duchenne muscular dystrophy - a pilot study using mixed methods. Eur J Paediatr Neurol. 2016;20(4):630-8. Doi: https://doi.org/10.1016/j.ejpn.2016.03.002

El-Aloul B, Speechley KN, Wei Y, Wilk P, Campbell C. Fatigue in young people with Duchenne muscular dystrophy. Dev Med Child Neurol. 2020;62(2):245-51. Doi: https://doi.org/10.1111/dmcn.14248

Toussaint M, Soudon P, Kinnear W. Effect of non-invasive ventilation on respiratory muscle loading and endurance in patients with Duchenne muscular dystrophy. Thorax. 2008;63(5):430-4. Doi: https://doi.org/10.1136/thx.2007.084574

Ferreira, VR. Escala de distúrbios do sono em crianças: tradução, adaptação cultural e validação [Dissertação]. São Paulo: Universidade Federal de São Paulo; 2009.

Evans A, Vingelen MB, Yu C, Baird J, Murray P, Bryant P. Nausea in numbers: electronic medical record nausea and vomiting assessment for children with cancer. J Pediatr Oncol Nurs. 2020;37(3):195-203. Doi: https://doi.org/10.1177/1043454219900467

Damani A, Salins N, Ghoshal A, Muckaden M. Specialist Pediatric Palliative Care Prescribing Practices: A Large 5-year Retrospective Audit. Indian J Palliat Care. 2016;22(3):274-281. Doi: https://doi.org/10.4103/0973-1075.185033

Monteiro DR, Almeida MA, Kruse MHL. Tradução e adaptação transcultural do instrumento Edmonton Symptom Assessment System para uso em Cuidados Paliativos. Rev Gaúcha Enferm. 2013;34(2):163-71. Doi: https://doi.org/10.1590/S1983-14472013000200021

Silva FC, Thuler LC. Cross-cultural adaptation and translation of two pain assessment tools in children and adolescents. J Pediatr (Rio J). 2008;84(4):344-9. Doi: https://doi.org/10.2223/JPED.1809

Iwabe C, Miranda-Pfeilsticker BH, Nucci A. Medida da função motora: versão da escala para o português e estudo de confiabilidade. Rev Bras Fisioter. 2008;12(5):417-24. Doi: https://doi.org/10.1590/S1413-35552008000500012

Pagano M, Gauvreau K. Principles of biostatistics. New York: CRC; 2018. Doi: https://doi.org/10.1201/9780429489624

Craig F, Henderson EM, Bluebond-Langner M. Management of respiratory symptoms in paediatric palliative care. Curr Opin Support Palliat Care. 2015;9(3):217-26. Doi: https://doi.org/10.1097/SPC.0000000000000154

Gocheva V, Schmidt S, Orsini AL, Hafner P, Schaedelin S, Rueedi N, et al. Association between health-related quality of life and motor function in ambulant and nonambulant Duchenne muscular dystrophy patients. J Child Neurol. 2019;34(14):873-85. Doi: https://doi.org/10.1177/0883073819865681

Brooks JV, Poague C, Formagini T, Sinclair CT, Nelson-Brantley HV. The Role of a Symptom Assessment Tool in Shaping Patient-Physician Communication in Palliative Care. J Pain Symptom Manage. 2020;59(1):30-8. Doi: https://doi.org/10.1016/j.jpainsymman.2019.08.024

Published

2020-06-30

Issue

Section

Original Article

Funding data

How to Cite

1.
Pavão JR, Lizzi EA da S, Souza MA de, Sobreira CF da R, Chaves TC, Mattiello-Sverzut AC. Evaluation of symptoms in Duchenne muscular dystrophy: a palliative care strategy. Acta Fisiátr. [Internet]. 2020 Jun. 30 [cited 2024 Jul. 18];27(2):89-94. Available from: https://periodicos.usp.br/actafisiatrica/article/view/171476